A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non‐Hodgkin's lymphoma
暂无分享,去创建一个
C. Flowers | S. Lonial | J. Kaufman | H. Khoury | A. Langston | M. Lechowicz | R. Sinha | L. Nastoupil | Jonathon B. Cohen | J. Switchenko | J. Koff | L. Heffner | J. Cohen | Amanda Hutchison-Rzepka | Nassoma Bumpers | Amanda Colbert